Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis.
This study analyzed the initial presentation and revascularization outcomes of patients with radiation-induced renal artery stenosis, a rare complication of therapeutic irradiation. Of 11 patients with renal artery stenosis after irradiation, 7 patients fulfilled the following criteria: normotension before irradiation, radiation dose greater than 25 grays delivered to the renal arteries, associated perirenal radiation-induced lesions, and absence of arterial disease outside the radiation field. The median age at irradiation was 30 years, and the median local irradiation dose was 40 grays. The median time from irradiation to referral was 13 years. All patients were hypertensive at referral, with a median blood pressure (BP) of 171/102 mm Hg and median treatment score of two. The median glomerular filtration rate was 67 mL/min. Two patients had bilateral stenoses and 1 patient had stenosis affecting a single kidney. Stenoses were proximal in 6 patients and truncal in 1 patient, and all had the appearance of atherosclerotic stenosis. Percutaneous transluminal renal artery angioplasty (PTRA) was successful in 5 patients, but required multiple insufflations. PTRA failed in 1 patient, who subsequently underwent an aortorenal bypass. After a median follow-up of 36 months, 2 patients had died of noncardiovascular causes and 4 patients remained hypertensive, with a median BP of 136/85 mm Hg and median treatment score of two. No restenosis occurred, but aneurysms developed at the site of angioplasty in 1 patient. If hypertension occurs even decades after irradiation, a radiation-induced renal artery stenosis should be sought in patients who have undergone abdominal irradiation.
Fakhouri
F
F
Departments of Hypertension and Cardiovascular Radiology, Hôpital Européen Georges Pompidou, Paris, France.
La Batide Alanore
A
A
Rérolle
J P
JP
Guéry
B
B
Raynaud
A
A
Plouin
P F
PF
D000328:Adult; D000800:Angioplasty, Balloon; D001157:Arterial Occlusive Diseases / Q000209:etiology; D004380:Duodenal Obstruction / Q000209:etiology; D017809:Fatal Outcome; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007680:Kidney Neoplasms / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D012078:Renal Artery Obstruction / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D018239:Seminoma / Q000532:radiotherapy / Q000556:secondary; D009396:Wilms Tumor / Q000532:radiotherapy / Q000601:surgery